Почетна › Рак на бели дробови › Калифорнија
Клинички испитувања за Рак на бели дробови во Калифорнија
111 студии за Рак на бели дробови бараат учесници на локации во Калифорнија.
Градови во Калифорнија
- Los Angeles45 студии
- Baldwin Park24 студии
- San Diego23 студии
- San Francisco22 студии
- Sacramento22 студии
- Mountain View17 студии
- Santa Monica15 студии
- Irvine15 студии
- Orange14 студии
- Santa Rosa11 студии
- San Jose9 студии
- Vallejo9 студии
- Concord9 студии
- Roseville9 студии
- Long Beach9 студии
- Modesto8 студии
- Torrance7 студии
- Newport Beach7 студии
- Fremont7 студии
- Richmond7 студии
- Fresno7 студии
- Santa Clara6 студии
- Oakland6 студии
- San Bernardino6 студии
- Pleasanton6 студии
- San Leandro5 студии
- Daly City5 студии
- San Mateo4 студии
- Sunnyvale4 студии
- Anaheim4 студии
- Burbank4 студии
- Fullerton4 студии
- Glendale4 студии
- Stockton4 студии
- Huntington Beach3 студии
- Berkeley3 студии
- Santa Maria3 студии
- Upland3 студии
- Indio3 студии
- Riverside3 студии
Официјален текст на студијата (англиски)
The Vanguard Study: Testing a New Way to Screen for Cancer
- Kaiser Permanente-Division of Research, Pleasanton
Се регрутираДобредојдени се здрави волонтери
Возраст од 45 до 75 · Сите полови · Ажурирано 5.10.2026 · NCT06995898A Study of ZW251 in Participants With Advanced Solid Tumors
- UCSF Comprehensive Cancer Center, San Francisco
- University of California Los Angeles - Cancer Care - Santa Monica (UCLA), Santa Monica
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT07164313Safety and Efficacy of OBX-115 in Advanced Solid Tumors
- The Angeles Clinic and Research Institute (Melanoma), Los Angeles
- USC Norris Comprehensive Cancer Center (Melanoma/NSCLC), Los Angeles
- Stanford Cancer Institute (Melanoma/NSCLC), Stanford
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT06060613Panitumumab-IRDye800 in Detecting Cancer in Participants With Lung Cancer During Surgery
- Stanford University, School of Medicine, Palo Alto
Се регрутираФаза 1/2
Возраст 19 и постари · Сите полови · Ажурирано 5.10.2026 · NCT03582124Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
- Kaiser Permanente-Anaheim, Anaheim
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- Sutter Auburn Faith Hospital, Auburn
- и уште 56
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04267848Osimertinib With or Without Bevacizumab as Initial Treatment for Patients With EGFR-Mutant Lung Cancer
- Kaiser Permanente-Deer Valley Medical Center, Antioch
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- и уште 23
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 5.10.2026 · NCT04181060Smoking Cessation CM for Veterans With or at Risk for Cancer
- San Francisco VA Medical Center, San Francisco, CA, San Francisco
Се регрутираДобредојдени се здрави волонтери
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT06432985The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
- University of San Diego Moores Cancer Center, La Jolla
- UCLA Jonsson Comprehensive Cancer Center, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 1/2
Возраст 12 и постари · Сите полови · Ажурирано 2.10.2026 · NCT04585750Distance-Based Exercise to Preserve Function and Prevent Disability
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- Kaiser Permanente Fresno Orchard Plaza, Fresno
- и уште 10
Се регрутира
Возраст 18 и постари · Сите полови · Ажурирано 2.10.2026 · NCT07059884Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
- Mission Hope Medical Oncology - Arroyo Grande, Arroyo Grande
- PCR Oncology, Arroyo Grande
- AIS Cancer Center at San Joaquin Community Hospital, Bakersfield
- и уште 20
Се регрутираНабљудувачка студијаДобредојдени се здрави волонтери
Возраст од 40 до 75 · Сите полови · Ажурирано 2.10.2026 · NCT05334069A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
- City of Hope, Duarte
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06172478Immunotherapy After Surgery for People Who Have No Remaining Cancer Cells After Standard Treatment for Early-Stage Non-Small Cell Lung Cancer, INSIGHT Trial
- Tower Cancer Research Foundation, Beverly Hills
- Kaiser Permanente Dublin, Dublin
- Kaiser Permanente-Fremont, Fremont
- и уште 20
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06498635Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors
- City of Hope Comprehensive Cancer Center, Duarte
- University of California Los Angeles, Los Angeles
- University of California San Diego Moores Cancer Center, San Diego
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 1.10.2026 · NCT06625775Neladalkib (NVL-655) for TKI-naive Patients With Advanced ALK-Positive NSCLC
- Hoag Hospital Newport Beach, Newport Beach
- University of California, Irvine Health, Orange
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 30.9.2026 · NCT06765109A Study of PHN-012 in Patients With Advanced Solid Tumors
- PHN-012-001 Site, Los Angeles
- PHN-012-001 Site, San Diego
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT07127874Study of Daraxonrasib (RMC-6236) in Patients With RAS Mutated NSCLC (RASolve 301)
- MemorialCare Long Beach Medical Center, Long Beach
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 29.9.2026 · NCT06881784Symbiotic-Lung-14: A Study to Learn About the Study Medicine Called PF08634404 in Combination With Chemotherapy in Adult Participants With Transformed Small Cell Lung Cancer
- City of Hope National Medical Center, Duarte
- UC San Diego Medical Center - Encinitas, Encinitas
- City of Hope Lennar Foundation Cancer Center, Irvine
- и уште 9
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07476287A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]
- GSK Investigational Site, Los Angeles
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 28.9.2026 · NCT07099898A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
- Beverly Hills Cancer Center ( Site 0070), Beverly Hills
- UCLA Clinical & Translational Research Center (CTRC) ( Site 0033), Los Angeles
- Hoag Memorial Hospital Presbyterian ( Site 0096), Newport Beach
- и уште 2
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06312137A Study Evaluating Sotorasib Platinum Doublet Combination Versus Pembrolizumab Platinum Doublet Combination as a Front-Line Therapy in Participants With Stage IV or Advanced Stage IIIB/C Nonsquamous Non-Small Cell Lung Cancers (CodeBreaK 202)
- Sansum Clinic, Santa Barbara
Се регрутираФаза 3
Возраст од 18 до 100 · Сите полови · Ажурирано 25.9.2026 · NCT05920356Symbiotic-Lung-01 : A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer
- Oncura Health - Anaheim, Anaheim
- Memorial Care Orange Coast Medical Center Attn, Fountain Valley
- MemorialCare Orange Coast Medical Center, Fountain Valley
- и уште 20
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07222566A Study to Investigate Ubamatamab With and Without Marlotamig (REGN7075) in Adult Participants With Advanced/Metastatic Non-Small Cell Lung Cancer (NSCLC)
- The City of Hope Orange County Lennar Foundation Cancer Center, Irvine
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07154290This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.
- Providence Medical Foundation, Fullerton
- Providence St. Jude Medical Center Virginia K. Crosson Cancer Center and Infusion Center, Fullerton
- Providence St. Jude Medical Center, Fullerton
- и уште 1
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT06758401Symbiotic-Lung-10: A Study to Learn About PF-08634404 Alone or in Combination in Early-stage or Locally Advanced NSCLC
- Stanford Cancer Institute, Stanford
- Stanford Hospital and Clinics, Stanford
- Stanford Hospital Investigational Drug Services, Stanford
Се регрутираФаза 2
Возраст 18 и постари · Сите полови · Ажурирано 25.9.2026 · NCT07489066A Registry for People With Lung Cancer
- University of California San Diego (Data collection), San Diego
Се регрутираНабљудувачка студија
Возраст 18 и постари · Сите полови · Ажурирано 24.9.2026 · NCT06424327Neoadjuvant and Adjuvant Treatment in Resectable Non-small Cell Lung Cancer
- Research Site, Los Angeles
Се регрутираФаза 2
Возраст од 18 до 95 · Сите полови · Ажурирано 23.9.2026 · NCT05061550A Study of Risvutatug Rezetecan in Combination With Ivonescimab in Participants With Advanced Solid Tumors (EMBOLD PanTumour-103)
- GSK Investigational Site, Los Angeles
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07602855A Study to Compare the Combination of Navlimetostat (BMS-986504) With Pembrolizumab and Chemotherapy Versus Placebo Plus Pembrolizumab and Chemotherapy in First-line Metastatic Non-small Cell Lung Cancer Participants With Homozygous MTAP Deletion
- Local Institution - 0497, Los Alamitos
- USC/Norris Comprehensive Cancer Center, Los Angeles
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 23.9.2026 · NCT07063745Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
- John Muir Clinical Research Center, Concord
- University Of California - San Diego Moores Cancer Center, La Jolla
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06712316Study of Izalontamab Brengitecan (BMS-986507) Versus Platinum-Pemetrexed for EGFR-mutated Non-small Cell Lung Cancer After Failure of EGFR TKI Therapy (IZABRIGHT-Lung01)
- UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care building, Irvine
- University of California, Irvine (UCI) Health - UC Irvine Medical Center, Orange
Се регрутираФаза 2/3
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT07100080Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
- UC IRVINE Health, Orange
- UC Davis Comprehensive Cancer Center, Sacramento
- Stanford Cancer Institute, Stanford
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 22.9.2026 · NCT06128551Empowering Patients' Lung Cancer Screening Uptake (Empower LCS/Call+)
- UCI Health Family Health Center - Anaheim, Anaheim
- UCI Health - Costa Mesa, Costa Mesa
- CHAO Family Comprehensive Cancer Center- Irvine, Irvine
- и уште 10
Се регрутира
Возраст од 50 до 80 · Сите полови · Ажурирано 21.9.2026 · NCT07711691BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)
- Los Alamitos Hematology/Oncology Medical Group, Glendale
- MemorialCare Todd Cancer Institute, Long Beach
- Valkyrie Clinical Trials, Los Angeles
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT07625644Testing the Combination of an Anti-cancer Drug, Iadademstat, With Other Anti-cancer Drugs (Atezolizumab or Durvalumab) at Improving Outcomes for Small Cell Lung Cancer
- City of Hope Comprehensive Cancer Center, Duarte
- City of Hope at Irvine Lennar, Irvine
- UC San Diego Moores Cancer Center, La Jolla
- и уште 1
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 17.9.2026 · NCT06287775Phase 1/2 Trial of S241656 in Selected RAS/MAPK Mutation- Positive Malignancies
- The Angeles clinic - A cedars SINAI AFFILIATE, Los Angeles
- USC Norris Comprehensive Cancer Center, Los Angeles
- University of California, San Francisco (UCSF), San Francisco
Се регрутираФаза 1/2
Возраст 18 и постари · Сите полови · Ажурирано 16.9.2026 · NCT05786924Open Label Study to Evaluate BL-M07D1 in HER2 Expressing Malignant Solid Tumors
- City of Hope, Duarte
- START - Los Angeles, Los Angeles
- Cedars Sinai, Los Angeles
- и уште 1
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 10.9.2026 · NCT06293898A Study of LY4050784 in Participants With Advanced or Metastatic Solid Tumors
- UCLA, Santa Monica
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06561685A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
- Cedars-Sinai Medical Center, Los Angeles
- BASS Cancer Center, Walnut Creek
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06119581A Study Evaluating the Efficacy and Safety of Divarasib and Pembrolizumab Versus Pembrolizumab and Pemetrexed and Carboplatin or Cisplatin in Participants With Previously Untreated, KRAS G12C-Mutated, Advanced or Metastatic Non-Squamous Non-Small Cell Lung Cancer
- Community Cancer Institute (CCI), Clovis
- Marin Cancer Care Inc, Greenbrae
- UCI Health-CIACC, Irvine
- и уште 6
Се регрутираФаза 3
Возраст 18 и постари · Сите полови · Ажурирано 8.9.2026 · NCT06793215A Study of Sofe-M in Participants With Selected Advanced Solid Tumors
- University of California, San Diego (UCSD) - Moores Cancer Center, La Jolla
Се регрутираФаза 1
Возраст 18 и постари · Сите полови · Ажурирано 4.9.2026 · NCT06400472Од ClinicalTrials.gov, податоци преземени 6.10.2026. Секоја студија ги поставува своите услови за вклучување; тимот на студијата одлучува кој може да учествува.